Importantly, the expression of some key antigen presentation pathway proteins was also significantly reduced, and was not responsive to IFN stimulation (Fig. 5e), predicting poor antigen presentation in TEdeff cells, which is a hallmark of evasion of anti-tumor immune attack in vivo33,34 and of resistance to immunotherapy in the clinic35. The gene discussed is IFNA1; the disease is neoplasm.